SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Rhea-AI Summary

SINTX Technologies (NASDAQ:SINT) entered securities purchase agreements for a $4.5 million private placement priced at-the-market under Nasdaq rules, issuing 1,882,845 common shares plus Class A and Class B warrants.

Together with a recent $0.5 million ATM sale, SINTX raised about $5.0 million for working capital, commercialization, business development and other strategic uses.

Positive

• Approximately $5.0 million total equity capital raised in recent weeks
• $4.5 million gross proceeds from June 2026 private placement
• Issuance of 1,882,845 Class A and 1,882,845 Class B warrants at $2.14 exercise price
• Financing priced at-the-market under Nasdaq rules
• Stated use of proceeds for commercialization and strategic opportunities

Negative

• New issuance of 1,882,845 common shares creates shareholder dilution
• Additional potential dilution from up to 3,765,690 warrant-exercisable shares
• Offering incurs fees and other expenses reducing net proceeds
• Registration rights create future resale overhang for new shares and warrant shares

News Market Reaction – SINT

+7.69% 7.1x vol

8 alerts

+7.69% Session close to close

+31.3% Peak Tracked

-7.7% Trough Tracked

$8.98M Market Cap

7.1x Rel. Volume

In the Jun 3 session, SINT gained 7.69%, reflecting a notable positive market reaction. Argus tracked a peak move of +31.3% during that session. Argus tracked a trough of -7.7% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. Trading volume was exceptionally heavy at 7.1x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +7.7% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +7.7% in the session following this news. A strong positive reaction aligns with the company’s need to reinforce its balance sheet after reporting modest cash and going-concern risk in recent filings. However, SINTX has relied repeatedly on equity-linked financings, including a prior private placement that coincided with a -19.63% move. Investors would have to weigh enthusiasm about additional funding against ongoing dilution capacity from warrants and existing resale registrations.

Key Figures

Private placement proceeds: $4.5 million Recent ATM raise: $500,000 Total recent equity capital: $5.0 million +5 more

8 metrics

Private placement proceeds $4.5 million Aggregate gross proceeds from current private placement before fees

Recent ATM raise $500,000 Completed purchase via at-the-market offering program

Total recent equity capital $5.0 million Approximate total equity capital raised in recent weeks

Shares in placement 1,882,845 shares Common stock issued in private placement

Class A warrant coverage 1,882,845 shares Shares underlying Class A Common Stock Purchase Warrants

Class B warrant coverage 1,882,845 shares Shares underlying Class B Common Stock Purchase Warrants

Warrant exercise price $2.14 per share Exercise price for both Class A and Class B warrants

Effective offering price $2.39 per unit Price per share plus accompanying warrants in the offering

Previous Private placement Reports

1 past event · Latest: Feb 26 (Negative)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 26	Private placement financing	Negative	-19.6%	Completed $5M private placement with stock and warrants to investors.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Historically, private placements for SINTX have coincided with notable negative price reactions, with the prior tagged event showing a -19.63% move following a similar at-the-market private placement.

Recent Company History

Looking at prior private placement activity, SINTX completed a $5 million at-the-market private placement on Feb 26, 2025, issuing common stock and immediately exercisable warrants to accredited investors. That transaction, also structured as a private placement under exemptions from registration, led to a -19.63% one-day move. Today’s capital raise, again involving common shares plus warrants and marketed to institutional and accredited investors, fits this established pattern of funding operations through equity-linked deals.

Key Terms

private placement, warrants, at-the-market offering program, accredited investors, +4 more

8 terms

private placement financial

"shares of common stock in a private placement priced at-the-market under Nasdaq rules."

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

warrants financial

"Common Stock Purchase Warrants to purchase up to an aggregate of 1,882,845 shares"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

at-the-market offering program financial

"through its at-the-market offering program, the Company has raised approximately $5.0 million"

An at-the-market offering program lets a company sell newly issued shares directly into the open market at current trading prices through a broker, rather than issuing a large block of stock all at once. It matters to investors because it provides the company a flexible way to raise cash over time, which can dilute existing shares gradually and affect earnings per share and stock price depending on how much and when shares are sold—think of it as a faucet the company can open or close to add supply to the market.

accredited investors financial

"The securities were offered only to accredited investors."

Accredited investors are individuals or entities considered to have enough financial knowledge and resources to understand and handle more complex and risky investments. They are often allowed to participate in private investment opportunities that are not available to the general public, similar to how experienced players might access exclusive clubs or events. This status helps ensure that investors can manage potential risks and rewards appropriately.

Section 4(a)(2) regulatory

"in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended"

Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.

Regulation D regulatory

"Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”) and Regulation D promulgated thereunder"

Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

registration rights agreement regulatory

"Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements"

A registration rights agreement is a contract that gives investors the option to have their ownership stakes officially registered with the government, making it easier to sell their shares later. This agreement matters because it provides investors with a clearer path to cash out their investments if they choose, offering more liquidity and confidence in their ability to sell their holdings when desired.

registration statements regulatory

"agreed to file one or more registration statements with the SEC covering the resale of the shares"

Registration statements are detailed documents companies file with securities regulators when they plan to offer shares or other securities to the public. They act like a recipe and instruction manual, listing a company’s business, finances, management, risks and how the offering will work, so investors can judge value and potential downsides. For investors, these filings provide the official, legally required facts needed to make informed decisions and spot warning signs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, Utah, June 03, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced biomaterials company focused on developing silicon nitride technologies for medical applications, today announced that it has entered into securities purchase agreements with institutional and accredited investors pursuant to which the Company agreed to issue and sell an aggregate of 1,882,845 shares of common stock in a private placement priced at-the-market under Nasdaq rules.

In addition, the Company issued to the investors (i) Class A Common Stock Purchase Warrants to purchase up to an aggregate of 1,882,845 shares of common stock and (ii) Class B Common Stock Purchase Warrants to purchase up to an aggregate of 1,882,845 shares of common stock. The warrants are exercisable immediately at an exercise price of $2.14 per share. The Class A Warrants will expire five years from the date of issuance and the Class B Warrants will expire two years from the date of issuance. The combined effective offering price for each share of common stock and accompanying warrants to be issued is $2.39. The offering is expected to close on or about June 3, 2026, subject to satisfaction of customary closing conditions.

The aggregate gross proceeds to the Company from the private placement were $4.5 million before deducting fees and other offering expenses. Together with a previously completed $500,000 purchase of the Company's common stock through its at-the-market offering program, the Company has raised approximately $5.0 million of equity capital in recent weeks. The Company intends to use the net proceeds from the offering for general corporate purposes, including working capital, commercialization activities, business development initiatives and other strategic opportunities.

“We are pleased to complete this financing and appreciate the strong support from well known Life Science investors,” said Eric Olson, Chairman of the Board and Chief Executive Officer of SINTX Technologies. “We believe this transaction strengthens our balance sheet and enhances our ability to pursue our strategic objectives while continuing to advance the development and commercialization of our silicon nitride technology platform.”

The shares of common stock and warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”) and Regulation D promulgated thereunder and, have not been registered under the Act or applicable state securities laws. Accordingly, the shares of common stock, the warrants and the shares of common stock underlying the warrants may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (“SEC”) or an applicable exemption from such registration requirements. The securities were offered only to accredited investors.

Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock issued in the offering and the shares of common stock issuable upon exercise of the Class A Warrants and Class B Warrants.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

For more information on SINTX Technologies or its biomaterial platforms, visit www.sintx.com.

About SINTX

Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. With thousands of medical devices implanted since 2008 and nearly two decades of peer-reviewed research, SINTX has established itself as a leader in high-performance biomaterials that enhance clinical outcomes and patient safety. Supported by a strong patent portfolio, U.S.-based manufacturing, and strategic industry partnerships, the company continues to expand its technology platform through innovation and market diversification, including the recently FDA-cleared SINAPTIC Foot & Ankle Implant System for reconstructive surgery.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Forward-looking statements can be identified by words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions. These forward-looking statements include, without limitation, statements regarding the anticipated use of proceeds from the private placement, the Company’s ability to regain and maintain compliance with Nasdaq continued listing requirements, the filing and effectiveness of one or more registration statements covering the resale of securities issued in the private placement, future commercialization opportunities, development of new products and technologies, strategic initiatives, operational plans and future business prospects. Forward-looking statements are based on management’s current expectations, assumptions and projections and are not guarantees of future performance. Actual results may differ materially from those expressed or implied in these forward-looking statements due to a variety of risks and uncertainties, including, without limitation, risks related to market and economic conditions, the Company’s ability to maintain compliance with Nasdaq continued listing standards, the Company’s ability to obtain additional financing when needed, risks associated with commercialization of the Company’s technologies and products, the development of new product opportunities, regulatory developments, competition, changes in customer demand and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission (“SEC”), including the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC on March 20, 2026, and subsequent filings with the SEC. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date they are made. Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances after the date of this press release.

SINTX Contacts:

Investor Relations
P: 801-839-3502
E: IR@sintx.com

FAQ

What did SINTX Technologies (NASDAQ:SINT) announce on June 3, 2026?

SINTX announced it raised about $5.0 million of equity capital. According to SINTX, this includes a $4.5 million private placement of common stock and warrants plus a prior $500,000 sale through its at-the-market offering program.

What are the key terms of SINTX (SINT) June 2026 private placement?

The private placement totals $4.5 million in gross proceeds. According to SINTX, investors receive 1,882,845 common shares plus Class A and Class B warrants, with both warrant classes exercisable immediately at $2.14 per share at a combined price of $2.39.

How many new shares and warrants did SINTX (SINT) issue in this financing?

SINTX agreed to issue 1,882,845 new common shares in the private placement. According to SINTX, investors also received Class A warrants for 1,882,845 shares and Class B warrants for 1,882,845 shares, all exercisable immediately at $2.14 per share.

How will SINTX use the proceeds from its June 2026 capital raise?

The proceeds will support general corporate purposes. According to SINTX, intended uses include working capital, commercialization activities, business development initiatives and other strategic opportunities related to advancing its silicon nitride technology platform in medical applications.

What are the expiration dates of SINTX (SINT) Class A and Class B warrants?

The two warrant classes have different lifespans. According to SINTX, the Class A warrants expire five years from issuance, while the Class B warrants expire two years from issuance, with both exercisable immediately at an exercise price of $2.14 per share.

Is the June 2026 SINTX (SINT) private placement registered with the SEC?

The securities were issued in a private placement and are not initially registered. According to SINTX, the company will file registration statements covering resale of the common shares and the shares issuable upon exercise of the Class A and Class B warrants.